Telemos Capital has acquired Helios, a leading global healthcare communications firm, from NorthEdge, following the company's significant growth in revenue and operations.

Target Information

Helios is a full-service, independent global healthcare communications and strategic consultancy based in Cheshire. The company specializes in providing tailored solutions to global pharmaceutical clients, covering a diverse range of services such as medical writing, advisory boards, training, and symposia.

Ranking 17th on the 2020 Sunday Times FastTrack 100, Helios has demonstrated impressive growth driven by a commitment to excellence in service delivery, underpinned by significant investments in its workforce and a strong team culture.

Industry Overview

The healthcare communications industry in the UK has seen remarkable growth in recent years, fueled by the increasing need for pharmaceutical companies to effectively engage with healthcare professionals and

View Source

Similar Deals

Aya Healthcare Locum’s Nest

2025

Other Private Equity Healthcare Facilities & Services (NEC) United Kingdom
Foresight Group MyWay Digital Health Ltd

2025

Other Private Equity Healthcare Facilities & Services (NEC) United Kingdom
Keensight Capital Bedfont Scientific

2025

Other Private Equity Medical Diagnostic & Testing Equipment United Kingdom
LDC Medray Group

2024

Other Private Equity Healthcare Facilities & Services (NEC) United Kingdom
Calibre Scientific Greyhound Chromatography and Allied Chemicals Ltd.

2024

Other Private Equity Pharmaceuticals (NEC) United Kingdom
Calibre Scientific Invitech Ltd.

2024

Other Private Equity In-Vivo Diagnostic & Testing Substances United Kingdom

Telemos Capital

invested in

Helios

in 2024

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert